Soluble membrane antigens of brain tumors.I. Controlled testing for cell-mediated immune responses in a long surviving glioblastoma multiforme patient (Q40089614)

From Wikidata

Jump to navigation Jump to search

scientific article published on August 1, 1977

Language	Label	Description	Also known as
English	Soluble membrane antigens of brain tumors.I. Controlled testing for cell-mediated immune responses in a long surviving glioblastoma multiforme patient	scientific article published on August 1, 1977

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Soluble membrane antigens of brain tumors.I. Controlled testing for cell-mediated immune responses in a long surviving glioblastoma multiforme patient (English)

reason for preferred rank

most precise value

1 reference

10.1002/1097-0142(197708)40:2<660::AID-CNCR2820400211>3.0.CO;2-A

https://api.crossref.org/works/10.1002/1097-0142(197708)40:2%3C660::AID-CNCR2820400211%3E3.0.CO;2-A

28 May 2022

Soluble membrane antigens of brain tumors. I. Controlled testing for cell-mediated immune responses in a long surviving glioblastoma multiforme patient (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A196738

28 May 2022

1 reference

based on heuristic

inferred from title

neoplasm antigens

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A196738

28 May 2022

cell-mediated immunity

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A196738

28 May 2022

1 reference

10.1002/1097-0142(197708)40:2<660::AID-CNCR2820400211>3.0.CO;2-A

https://api.crossref.org/works/10.1002/1097-0142(197708)40:2%3C660::AID-CNCR2820400211%3E3.0.CO;2-A

28 May 2022

author name string

M. H. Hitchcock

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A196738

28 May 2022

A. C. Hollinshead

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A196738

28 May 2022

P. Chretien

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A196738

28 May 2022

H. V. Rizzoli

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A196738

28 May 2022

language of work or name

0 references

publication date

1 August 1977

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(197708)40:2%3C660::AID-CNCR2820400211%3E3.0.CO;2-A

1 reference

10.1002/1097-0142(197708)40:2<660::AID-CNCR2820400211>3.0.CO;2-A

https://api.crossref.org/works/10.1002/1097-0142(197708)40:2%3C660::AID-CNCR2820400211%3E3.0.CO;2-A

28 May 2022

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(197708)40:2%3C660::AID-CNCR2820400211%3E3.0.CO;2-A

1 reference

10.1002/1097-0142(197708)40:2<660::AID-CNCR2820400211>3.0.CO;2-A

https://api.crossref.org/works/10.1002/1097-0142(197708)40:2%3C660::AID-CNCR2820400211%3E3.0.CO;2-A

28 May 2022

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

40

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

660-666

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Serum mediated inhibition of the immunological reactions of the patient to his own tumour: a possible role for circulating antigen

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197708%2940%3A2%3C660%3A%3AAID-CNCR2820400211%3E3.0.CO%3B2-A

21 January 2018

Immunological Properties of Neoplastic Neural Tissues

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197708%2940%3A2%3C660%3A%3AAID-CNCR2820400211%3E3.0.CO%3B2-A

21 January 2018

Depressed cell-mediated immunity in patients with primary intracranial tumors. Characterization of a humoral immunosuppressive factor

1

1 reference

10.1002/1097-0142(197708)40:2<660::AID-CNCR2820400211>3.0.CO;2-A

https://api.crossref.org/works/10.1002/1097-0142(197708)40:2%3C660::AID-CNCR2820400211%3E3.0.CO;2-A

28 May 2022

LONG-TERM POSTOPERATIVE SURVIVAL IN TWO CASES OF GLIOBLASTOMA MULTIFORME.

4

1 reference

10.1002/1097-0142(197708)40:2<660::AID-CNCR2820400211>3.0.CO;2-A

https://api.crossref.org/works/10.1002/1097-0142(197708)40:2%3C660::AID-CNCR2820400211%3E3.0.CO;2-A

28 May 2022

Immunological Enhancement as Studied by Cell Culture Techniques

6

1 reference

10.1002/1097-0142(197708)40:2<660::AID-CNCR2820400211>3.0.CO;2-A

https://api.crossref.org/works/10.1002/1097-0142(197708)40:2%3C660::AID-CNCR2820400211%3E3.0.CO;2-A

28 May 2022

Delayed-hypersensitivity reactions to soluble membrane antigens of human malignant lung cells.

9

1 reference

10.1002/1097-0142(197708)40:2<660::AID-CNCR2820400211>3.0.CO;2-A

https://api.crossref.org/works/10.1002/1097-0142(197708)40:2%3C660::AID-CNCR2820400211%3E3.0.CO;2-A

28 May 2022

Immunological studies of human gliomas.

10

1 reference

10.1002/1097-0142(197708)40:2<660::AID-CNCR2820400211>3.0.CO;2-A

https://api.crossref.org/works/10.1002/1097-0142(197708)40:2%3C660::AID-CNCR2820400211%3E3.0.CO;2-A

28 May 2022

Tumor-specific membrane antigens in established cell lines from gliomas.

13

1 reference

10.1002/1097-0142(197708)40:2<660::AID-CNCR2820400211>3.0.CO;2-A

https://api.crossref.org/works/10.1002/1097-0142(197708)40:2%3C660::AID-CNCR2820400211%3E3.0.CO;2-A

28 May 2022

The human rosette-forming cell as a marker of a population of thymus-derived cells

15

1 reference

10.1002/1097-0142(197708)40:2<660::AID-CNCR2820400211>3.0.CO;2-A

https://api.crossref.org/works/10.1002/1097-0142(197708)40:2%3C660::AID-CNCR2820400211%3E3.0.CO;2-A

28 May 2022

Identifiers

10.1002/1097-0142(197708)40:2<660::AID-CNCR2820400211>3.0.CO;2-A

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40089614&oldid=1797724464"